# Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors

> **NCT01867879** · PHASE1 · COMPLETED · sponsor: **Taiho Oncology, Inc.** · enrollment: 44 (actual)

## Conditions studied

- Advanced Solid Tumors (Excluding Breast Cancer)

## Interventions

- **DRUG:** TAS-102
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01867879
- **Lead sponsor:** Taiho Oncology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2014-08
- **Final completion:** 2015-04
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2024-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01867879

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01867879, "Study to Evaluate the Cardiac Safety of TAS-102 in Patients With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01867879. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*